Connect with us


“We are terrified to say the word ‘vagina'”- the founder educating the world on reproductive health

After years of being ignored and dismissed, Golnoush Golshirazi was diagnosed with endometriosis



Dr Golnoush Golshirazi, co-founder and CEO of ScreenMe

Vaginal health is an essential part of a woman’s overall health. Yet, misconceptions surrounding this topic often lead individuals to feel dirty or ashamed when experiencing problems.

The lack of research into vaginal health and women’s health more generally seems only to perpetuate these misunderstandings, leaving women suffering in silence.

Dr Golnoush Golshirazi knows this too well. After years of being ignored and dismissed by healthcare professionals, she was diagnosed with endometriosis.

Wanting to make a change, the now researcher and women’s health advocate built her own business and launched ScreenMe, a platform that screens for every bacteria present in the vaginal microbiome and helps women better understand their reproductive health. She sat down with us to share her story.

Hi Golnoush, could you tell us a bit more about your background?

My background is molecular biology, with a PhD in genetics.

What inspired you to create ScreenMe?

My own personal health journey was what really ignited my passion to help others in the health space. It took thousands of pounds and many years until I got my endometriosis diagnosis. I felt constantly dismissed, ignored by professionals and unable to perform at my very best.

I always remember getting my period during one of my final exams for my university degree. I literally couldn’t move from my bed, and after ringing up, the invigilators were able to bring me my exam paper at least – however, the fact that I had to sit an exam when all I could think about was the huge pain I was experiencing (and be supposed to feel ‘grateful’ for this), is something that I will always remember.

After receiving my endometriosis diagnosis, I took a look back at this long and painful journey and vowed that I wanted to work to make sure this changed for others.

I saw that I could really use my own knowledge and expertise to advance healthcare responses and assist in creating solutions that genuinely worked for people. It wasn’t just this, but the wish to create a space where people felt heard and had access to the science that can really change their life – as this was something I struggled to find and wish I had looking back.

How would you describe ScreenMe in a few words?

Wow, that is a hard one. In just a few words I would say: answers and solutions, with care. This is because ScreenMe brings cutting-edge science to those who need it, but also pairs such with professional guidance, education and genuine support, to create solutions that work for you as an individual.

What makes ScreenMe different?

ScreenMe’s main difference I would say comes from making cutting-edge science accessible to the general public and bringing together the scientific, medical and holistic field for support.

As a team of scientists, medical professionals and holistic practitioners, and experts within the women’s health space we have decades of experience between us. This allows us to separate fact from fiction and really give advice and solutions that work for our community.

In a world which is moving towards a preventative and holistic care model – our team is so passionate about this and works towards such every day. Our team is also why we focus on education and awareness. We are aware from our own experiences that so many people know so little about intimate health and its long-term implications for fertility, infection, and disease – so it is our team who have focused our strategy on first educating society on the topic.

Then people can make informed, evidenced decisions as to what care, testing or support they need (if at all). We are passionate about not trying to push the ‘hard-sell’ on our product, but empower people with the agency to make the decisions that are right for them.

In terms of technicalities. ScreenMe is the only UK-based company that provides NGS-based screening of vaginal and seminal samples for bacteria and yeast allowing identification of all species present at very high accuracy.

Do you feel there is a lack of awareness around the importance of the vaginal microbiome and vaginal health in general?

As a society we are terrified to even say the word ‘vagina’, let alone open up discussions around this or provide adequate education. Most people do not even know the difference between the vulva and the vagina; or do not know that there are actually seven holes in their intimate area (most think there are three!).

So many of the people with vaginas we see each day have no clue about the implications of the symptoms they have been experiencing, or even the basics on how to look after their intimate health. This lack of awareness also extends out into the medical community.

Vaginal ecosystem and the role of the vagina in the bigger picture of health is hardly spoken about at med school. So many concerns could be prevented or resolved if people only had access to the correct information and services – so this is honestly something that I could speak about all day.

Such a severe lack of education is why we include a free one-to-one consultation with a practitioner for each of our tests, so that results can be explained and solutions can be curated.

This is also why we have published our free online Vaginal Health Clinic on our site where we provide the latest information regarding the vaginal microbiome and how this relates to a whole host of concerns, including recurrent infection, miscarriage, IVF success, thrush, cancer risk and much more.

How do you think we could start educating people on these subjects?

For me, the two most important ways to do this is through schools and educating the healthcare system itself.

Firstly, regarding schools, it is simply not enough to learn about the reproductive organs and their very basic functions. We need to ensure that there is effective and detailed education for all genders on the many layers of health, which includes intimate health, the role of hormones, menstrual conditions and disorders, sexual health and wellbeing, menopause, fertility complications, and so much more.

Schools are such a brilliant access point to allow people to understand from an early age, how to look after themselves, how to protect their health, what symptoms to look for, and also how to interact and understand others who may be suffering from particular health concerns or conditions.

We also are really passionate about educating the healthcare community about this topic. You would be amazed at how little is often required to be learnt about intimate health and so we do a lot of work with practitioners to improve their knowledge on this topic – including webinars and broadcasts.

Vaginal health often comes with a lot of stigma. How did you find establishing your business in this sector?

We actually started focusing on women’s health care in general and it was only through listening to our community that we realised what a huge gap there was in understanding, testing, services and support for intimate health. So, while there have been barriers in this pivot, we ultimately have had a core community who are so appreciative of the work we do for them and want to hear more about vaginal health.

I think reading the many positive reviews that state how we have changed people’s lives, really keeps us motivated. However, having a business in this sector has been difficult when approaching investors.

Intimate health is not always something that people are comfortable speaking about, so it is sometimes difficult to present appropriate data on such, or have productive conversations. Yet this is something we are striving to change every day!

What obstacles have you encountered on this journey?

I guess the main obstacle I have faced is actually being a woman. We hear all the time how gender disparities reveal themselves in the workplace and in society as a whole – but I guess you never really realise the extent of this until you experience them first-hand yourself.

Particularly when looking for investment, it is difficult to always communicate some of the many struggles that women face daily, and present them as a consumer market – despite women making the majority of household health-related spending decisions!

I have even been in a room myself with an investor and my co-founder (who is a man), and the investor asked me for a tea and assumed that I was the assistant. It was only when we started the meeting and my co-founder asked me to answer the first question, that the investor realised the mistake he had made. Of course, instances like this do serve well to light a fire in my belly, but it is unrealistic to say that they aren’t sometimes difficult to navigate.

Where are you with ScreenMe now?

We are currently really focusing on our expansion of intimate health services. This has a multi-pronged approach including: providing top-quality thought leadership, providing our services globally and expanding the network with whom we work with.

Each month we are receiving more attention and onboarding more partners, practitioners, clinics and customers. We want to expand out outreach and awareness, so that intimate health is something everyone understands and makes a part of their routine check-ups. As we build momentum, we are so excited to see this future starting to take shape in front of us, even if there is still a way to go yet.

We have also recently launched our semen microbiome testing service. This is so we can help everyone with their intimate health. The semen microbiome is also really important for a range of similar reasons, including fertility, IVF success, infection risk, and risk of disease.

Further, in the case of heterosexual partners, this allows us to treat couples as a pair and prevent reinfections – as there is no use for only one person to do all of the work to optimise intimate health, when their sexual partner is doing nothing!

What are you looking to achieve with ScreenMe?

We want to achieve a world in which intimate and reproductive health is a key feature of education and research and people are able to get the testing, support and services required to improve such. It is crazy to me that we are still using swab culture methods to investigate intimate health, when this was a method devised over 100 years ago.

NGS is an available technology which provides much greater accuracy and is able to screen 100 per cent of the bacteria present, rather than a selected panel of pre-selected bacteria as used in swab culture or PCR methods.

ScreenMe works to make this technology available to everyone, so that they can understand the full context of their microbiome, rather than just get a few pieces of the puzzle. So, really what we are working towards is empowering everyone with their intimate health and at the same time seriously powering up research which is crucial for better intimate and reproductive health.

Where do you see the company in the future?

I see ScreenMe as the go-to platform for people globally when it comes to their intimate and reproductive health. I see a trustworthy, science-based place where men and women find answers, solutions, support and education with all of this leading to lower risk of non-communicable diseases across society.

I have big ambitions, so I don’t just want to see ScreenMe changing and growing in the future, but I want to see the whole of intimate health as we know it changing due to ScreenMe’s work!

Dr Golnoush Golshirazi is the co-founder and CEO of ScreenMe. She is a Cambridge graduate, scientist and entrepreneur who advocates for women’s equality within the healthcare system. 


‘You don’t need to have it all figured out’- the founder getting more women into tech



Safa Jemai, founder and CEO of Víkonnekt

Safa Jemai knew she wanted to study computer science from a young age, but it wasn’t until she moved to Iceland from sunny Tunisia that she embarked on the journey of entrepreneurship, building the software and product development firm Víkonnekt. Here, she tells us how she got into tech and why she would like more women to do the same.

Safa, could you tell us a bit more about your background?

I was born in a middle class family in Bizerte, a small town in North Tunisia. My parents knew from the start that the only way to see their kids succeed in a tremendously challenging environment was to study and study very hard.

I was encouraged from a very early age to excel in maths, science and physics but later on when I was 12, I decided to take the path of computer science.

In 2018, I made the decision to move from Tunisia to Iceland to study the Icelandic language and continue my degree in computer science, receiving my degree in both from Iceland’s top university.

I had the opportunity to work on two projects that combined knowledge from my studies: a language processing project to preserve the Icelandic language in the age of AI – at a time when small nation languages have been at their most vulnerable – and entering a national incubator programme with a mobile app to help people more readily and easily learn Icelandic.

I put my focus on building two companies that serve multiple purposes, including fostering a diverse, inclusive tech industry and inspiring interests in different cultures and inclusivity across cultures.

What inspired you to create Vikonnekt?

I saw an opportunity in the market. While I was still in university, I worked also as a developer for a few start-ups and as a freelancer project manager.

I noticed the innovative ecosystem in Iceland is growing and we have more and more exciting companies with more entrepreneurs, but at the same time we have a need for more IT specialists.

I thought I could leverage my connections in Tunisia and build a strong team that could work remotely with another team based in Iceland and Víkonnekt was born.

I reached out to a few entrepreneurs and asked them about their experiences hiring tech people and implementing software products and in summer 2021, we officially launched Víkonnekt.

How would you describe Vikonnekt in a few words?

Víkonnekt is focused on providing third party technical development services to Nordic tech enterprises and companies and supporting the technical due diligence process for venture capital firms— as well as leveraging the technical development expertise of talented folks from Tunisia’s emerging technology sector.

 What makes Vikonnekt different?

Like other projects that I have been working on, Víkonnekt serves a multitude of purposes. Perhaps most notably, the company’s work showcases the new opportunities in North Africa by expanding the Nordic and European viewpoint of tech development, beyond Eastern Europe, and into the African continent.

Tech talent in Tunisia struggle with garnering fair, equitable salary negotiation. This results in significant immigration to European countries and destroys Tunisia’s ability to compete in the innovation sector.

As hybrid and remote work becomes more and more viable, and the normalisation of tech outsourcing to previously underutilised nations, like Tunisia, gains traction, Vikonnekt fosters regional economic development. This is reinforced by offering talent in Tunisia higher salaries and amenable work cultures than current market norms.

It enables talent to stay connected to their home cultures and reduces economic and housing challenges across Europe, improving work efficiency and better business outcomes.

Víkonnekt blends two seemingly unrelated and often underestimated cultures together, hiring talented people for compelling technical projects, both from Iceland and Tunisia. Though Tunisia is a big tech talent hub, it rarely has the chance to be showcased in European media and can be overshadowed by ecosystems in the Middle East.

Víkonnekt opens new doors of understanding of Tunisian possibilities for companies in Iceland and the Nordics, with regard to taking projects offshore or outsourcing. Víkonnekt also demonstrates to the emerging Tunisian tech sector the wealth of possibilities in collaborating with European and Nordic enterprises, expanding business opportunities for both regions.

It’s still quite rare for women to found tech entities in Europe, let alone garner success by bootstrapping. Even in Iceland, the reining utopia of gender equality, the number of female-founded tech companies remains relatively low. Compound this with additional distinctions, such as immigrant-founded, non-christian founded or non-white founded entities, and the stats drop to daunting levels.

With Víkonnekt, our aim is to eliminate barriers for non-white, non-christian, immigrant women technologists and entrepreneurs and help them thrive in the tech and business world.

It’s no secret that women are in the minority in the tech industry. How is Vikonnekt solving this issue?

While it is always a work in progress, our strategy has been from the beginning to search for female talent in universities.

We found it helpful to advertise for end term projects that students can work on with us and when they finish it, we hire them in the company. This way we are able to attract female developers more easily, as they feel more confident to apply for the end term projects, as well as train them well while working on the internal product through their end term project.

What are some of the ways to attract and retain women in tech that you discovered while building Vikonnekt?

Companies need to make sure that they provide a collaborative environment where voices are heard and opinions are taken seriously.

Through my journey with Vikonnekt, I noticed that women tend to listen more than talk. This is good, but it tends to create some imbalance – all team members need to communicate their thoughts out loud and influence the decisions of the company.

Here comes the responsibility of managers to notice these behaviours and create a safe space for everyone to listen and speak as well. When female developers see that their opinions matter and they are heard then they appreciate that a lot and tend to choose to stay in that company as they know that when they speak, they will be heard. People in general don’t seek only high salaries or bonuses but also a place where they are respected and taken seriously.

What is something you wish you learned sooner about the tech industry?

I wish I was taught early in school that I don’t have to figure out everything from the beginning to be able to participate in cool projects. Confidence is more important than knowledge in most cases. People trust a more confident person even if they might be making a wrong decision.

I think we need to teach our kids to be confident and communicate their thoughts early on even if they don’t have the right answers.

What advice would you give to people in the tech industry looking to diversify their tech talent pipeline?

Attracting tech talent doesn’t start in universities, it requires much more effort. If societies want to reach more people, they need to start earlier in the process which means in primary schools – that’s where kids start developing their passions.

Governments could arouse kids’ curiosity through programmes in their studies either through schools or associations. My passion for tech started when I was still 12 as I joined the local association in my hometown where I had the chance to work on simple IT projects. Having not taken part in the association, where I started familiarising myself with creating simple software projects, and having not chosen computer science in high school, I would have not chosen to build a career in the tech industry.

When we ask kids what they want to be when they grow up, they tend to lean more towards jobs like a doctor, teacher or an astronaut – that’s because the environment introduces them to these positions at a very early age.

How about we use the same tactic and introduce them to software development when they are still young? I am not talking about familiarising them with using social media but much more than that; I am talking about helping them understand how these programmes are actually built.

To receive the Femtech World newsletter, sign up here.

Continue Reading


‘There’s a lot of medical gaslighting’: the entrepreneur shaking up the fertility industry in South Asia



Anna Haotanto, founder and CEO of Zora Health

Fertility treatments can be unnecessarily complicated and out of reach but they shouldn’t be, Anna Haotanto told herself when she stepped down from ABZD Capital – an investment and advisory firm she co-established – looking for a fresh start. 

Inspired by her own egg freezing experience and let down by the lack of innovation in reproductive care, she set up Zora Health, a Singapore-based digital platform that aims to simplify fertility care at no extra cost for the patients. Here, she tells us more.

Anna, tell us a bit about your background and what inspired you to create Zora Health.

My last role was the managing partner of ABZD Capital and I was on the board of directors for Gourmet Food Holdings after serving as the managing director and overseeing the company’s growth in technology, digital innovation, branding, marketing and human resources.

I also founded The New Savvy – Asia’s leading financial, investments and career platform for women. Before being a founder, I was in banking for 8 years in wealth management.

I’ve been working for 22 years, and I was ready for a break and a fresh start. I stepped down last year because we reached a big milestone and I was keen to explore more tech opportunities. In that period, I looked at a lot of ideas, but asked myself, “What problem do I feel passionate about? What is overlooked and underserved?”

It’s not about proving myself, but solving something I care deeply about. I’ve always been interested in healthcare. Throughout my journey, I’ve had a lot of health issues. Last year alone, I had five surgeries. I thought I was suffering from perimenopause and started learning more about the symptoms.

It was an interesting area that I didn’t know much about. I started deep diving, because if I have that problem, I might as well try to solve it or find somebody to help. I realised there were very few solutions here. However, I couldn’t find a single source of truth or a platform of trusted resources.

So, I went into fertility as egg freezing is a topic I’m familiar with as I’ve done it myself. It’s also a very overlooked US$54bn global market, and 44 per cent of treatments are in Asia.

Technology has changed a lot of the way we do things, the way we travel, the way we stay in hotels, and the way we commute. There are a lot of developments, but not in fertility care. In Southeast Asia, I believe, there are only three or four fertility tech companies, mostly hardware or e-commerce.

I thought it was a very interesting market: high quantum, underserved. But we don’t talk about it because there are barriers to entry, such as shame and guilt.

How would you describe Zora Health in a few words?

Zora Health is a one-stop reproductive health and family planning platform that integrates patients, corporate employers, and fertility care providers, simplifying the journey and enhancing accessibility for all parties.

Our comprehensive services include online and physical consultations with a global network of partner clinics, medical concierge services and expert support. We also provide corporate fertility education workshops to cultivate fertility-friendly work environments, which ultimately help companies attract and retain top talent.

What makes Zora Health different?

Our clients often encounter common barriers, such as lack of information, stigma surrounding fertility issues and concerns about the affordability of treatments. They are also unsure of their options, what the process is like and regulations in different countries. These barriers can significantly impact their family planning journey, leading to delays or hesitations in seeking care.

At Zora Health, we strive to address these challenges by providing personalised support, educational resources and partnerships with over 80 clinics across 16 countries to empower our clients to make informed decisions about their reproductive health.

We also provide corporate fertility education workshops to cultivate fertility-friendly work environments, which ultimately help companies attract and retain top talent.

Zora means light or dawn. To us, it signifies a new beginning, a new way of doing things. We are building solutions we wished existed.

Women’s health comes with a lot of stigma. How has this impacted you as a founder?

The more stigma and problems there are, the more opportunities we see for Zora Health. The more I speak to our patients and clients, the more I see how important the work is.

Over the past few months, I realised that fertility is a problem that people address when it’s a bit too late. A younger friend of mine was told that she could only retrieve one viable egg. She’s only 37, so I think it’s a real problem. It’s just a problem that has never been talked about.

How does it impact me? The work is very meaningful and honestly, I’m very surprised to have found something that I truly love and care deeply about. We have an opportunity to change lives and make an impact. Even when I pitch to investors, I tell them I’m not here for five years — I’m here for 10, 15 years. I hope this will be my last work because there’s nothing else I want in life.

What obstacles have you encountered on this journey?

I don’t like bringing up gender issues, but the problem exists. We know that two per cent of total funding goes to women. There are a lot of female analysts and associates, but they’re not the ones writing the cheques. When I fundraised, I experienced it myself.

One of the biggest challenges for femtech is that female healthcare is poorly understood. Most of the research money historically goes to male afflictions.

There’s also a lot of medical gaslighting. When my friends see doctors, they share their discomfort but are not understood. It’s not because doctors don’t want to solve the problem, but rather that they don’t understand it. There should be more research money spent on all this.

Two, if the people writing cheques are males, they may also need help understanding, not because they don’t want to, but because they are unaware. Many years ago, when speaking to a start-up founder in his office, I saw one of my friends who needed to pump breast milk.

She complained that she had to pump in the copier room. He was completely clueless when I asked the founder why he didn’t have a private room. He was only 33. It’s not necessarily a gender problem – at 33, I didn’t have kids and I didn’t know that you needed a room for privacy and pumping breast milk.

We’ve spoken to about 400 women now, and many women don’t know about the egg freezing process. I did it five years ago, and I still didn’t know the process until I wrote an article.

Where are you with Zora Health now?

We are serving our patients and have 80 clinic partners across 16 countries. In addition, we are currently focusing on working with corporations through corporate workshops and offering corporate benefits for reproductive health and family planning. This covers the whole spectrum of fertility, menopause, PCOS, endometriosis and more.

Where do you see the company in the future?

In the long term, our vision is to unlock possibilities for women’s healthcare in Asia. To provide women with choices so they can live their lives without limitations.

To do this, we need a few things. One: resources and knowledge. It’s about creating a knowledge platform for women. And then you need providers, and a large network of clinics. And last, which people don’t talk about, is financing.

When I was young, my mum had a few surgeries because of breast cancer. I was very scared because she was not eligible for insurance by the time I could buy her insurance.

Until today, I live with that fear. What happens if she has a life-threatening disease in the future? Can I afford it? Financing is very important, and that’s often something people miss.

Maybe one day I’ll have to use my service. I’m 40 this year. Struggling with PCOS for the past six years, it will be harder for me to get pregnant. If I ever want to have kids, I believe there is a high chance I need to have IVF and if I do, I will definitely be a Zora Health patient myself.

To receive the Femtech World newsletter, sign up here.

Continue Reading


Neurosexism: how this app could bridge the gender gap in Parkinson’s disease

There’s a fundamental gap in knowledge in how Parkinson’s disease manifests and affects women – could this app close it?



Richelle Flanagan, founder and CEO of My Moves Matter

Richelle Flanagan realised that something wasn’t quite right when she was writing in a client’s record card during a dietetic consultation and she noticed that her hands were shaking. She was three months pregnant at the time.

Shortly after the birth of her daughter she was diagnosed with young onset Parkinson’s disease (YOPD), a form of Parkinson’s which starts between the age of 21 and 40.

The condition affects the nervous system and the parts of the body controlled by the nerves and while it mostly includes the same symptoms of Parkinson’s disease – tremor, slowness of movement, muscle stiffness and balance problems – it impacts young people differently due to their unique life circumstances.

Richelle, for instance, noticed that her Parkinson’s symptoms were getting worse the week before her menstrual bleed.

“Other women with YOPD were saying the same thing. As a dietitian, I’ve always had an inquisitive mind, so I started looking at the research.”

She discovered that oestrogen receptors in the brain impact neurotransmitters like dopamine, which people with Parkinson’s lack. When oestrogen and progesterone levels drop before a woman’s menstrual bleeding, she found, dopamine levels are impacted, leading to a worsening of the Parkinson’s symptoms.

It was an aha moment which inspired her to conduct a global survey of women with Parkinson’s to better understand the changes.

“I surveyed around 240 women and 80 per cent of them reported the same issues I had around the menstrual cycle.

“However, more concerning was the lack of awareness or advice by neurologists on how to manage the symptoms – no one was talking about these things.”

The gender gap, Richelle realised, was not just limited to “bikini medicine”.


Although Parkinson’s disease seems to occur more commonly in men than women, it is estimated that 40 per cent of people living with the disease worldwide are women.

Data shows there is a fundamental gap in knowledge in how Parkinson’s disease manifests and affects women throughout their hormonal life cycle, resulting in unmet needs and adversely impacting women’s quality of life.

Current literature is scarce and conflicting with how the disease affects women. There are currently no official guidelines on how to manage Parkinson’s symptoms in this group.

“Lisa Mosconi, a famous neuroscientist, calls this neurosexism,” says Richelle. “It’s exactly what it is.”

In Parkinson’s, she goes on to explain, the main drug that people are given is levodopa, a medication which was developed before the FDA required drug makers to look at the differences between men and women.

“Although research shows that the drug is absorbed 25 per cent more in women, which can lead to more side effects, nothing is being done to tailor it to women’s differing metabolism.”

The gaps in research, coupled with the growing rates of Parkinson’s in women, prompted Richelle to take action.

As part of a DayOne digital hackathon, she proposed the development of a digital health app to help women track their Parkinson’s symptoms and My Moves Matter was born.

The app, which Richelle says has a “neuro-friendly” design, aims to help women understand the impact of their hormones on their symptoms, recognise patterns and make lasting positive changes. It includes a journal feature, which allows users to detail their symptoms, and is currently the only digital app in the world that tracks neurological symptoms across the menstrual cycle.

More importantly, the platform seeks to help women connect with each other, learn more about their condition and get involved in research.

“I firmly believe that there’s so much more that we could find answers to, through understanding women,” Richelle explains.

“We can unlock a lot of answers through our biology. Rather than seeing it as a woman’s thing, we should be seeing it as a whole plethora of research that could improve outcomes for people of all genders and sexes.”

Research is already underway to improve the lives of women living with Parkinson’s. Researchers at University College Cork (UCC) have collaborated with My Moves Matter on a world-first study that could completely transform how women manage the disease.

Participants will be able to log their symptoms on the app to collect data which it is hoped will lead to better patient-specific treatment and management of Parkinson’s disease.

“Many people think Parkinson’s disease only affects older white men,” Richelle says.

“The reality is that 40 per cent of people living with Parkinson’s are women and up to 30 per cent are under the age of 60. And while Parkinson’s is the fastest growing neurological condition in the world, there are no clinical guidelines for the management of symptoms worsening in relation to hormonal changes in women.

“My hope is that this study may help to lay the foundations for the development of such guidelines.”

Additionally, the founder says the findings could help develop My Moves Matter into a “personalised” support platform for people with Parkinson’s.

“Parkinson’s is a very disabling diagnosis. Our aim is to offer everyone the support they need, whether it’s related to diet, exercise or mental health, because there’s no cure for it, and there are no drugs to slow progression at the moment.

“I believe in empowering people and that’s what we ultimately want to do.”

The app can be found on You can participate in the study by filling out this survey.

Continue Reading


Copyright © 2023 Aspect Publishing Ltd. All Rights Reserved.